Xponential Fitness Inc (XPOF) PT Raised to $26 at Baird

Xponential Fitness Inc (XPOF) PT Raised to $30 at Jefferies

Jefferies analyst Randal Konik raised the price target on Xponential Fitness Inc (NYSE: XPOF) to $30.00 (from $18.00) while maintaining a Buy rating.

The analyst commented, "XPOF's 3Q results prove in-person fitness is coming back aggressively. Openings were strong and more importantly, mgmt continues to see... More

Xponential Fitness Inc (XPOF) PT Raised to $25 at Guggenheim, Sees Additional Upside Despite Rally

Guggenheim analyst John Heinbockel raised the price target on Xponential Fitness Inc (NYSE: XPOF) to $25.00 (from $16.00) while maintaining a Buy rating.

The analyst commented, "Although XPOFs shares have rallied ~65% since the July IPO (vs SPY +6%) on a combination of a stronger-than-expected... More

Xponential Fitness Inc (XPOF) PT Raised to $23 at Morgan Stanley

Morgan Stanley analyst Brian Harbour raised the price target on Xponential Fitness Inc (NYSE: XPOF) to $23.00 (from $21.00) while maintaining a Overweight rating.... More

After-Hours Stock Movers 11/11: (XPOF) (CODX) (BLNK) Higher; (SCM) Lower (more...)

After-Hours Stock Movers

Xponential Fitness, Inc. (NYSE: XPOF) 20.7% HIGHER; reported Q3 EPS of ($0.31), $0.19 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $40.9 million versus the consensus estimate of $33.96 million. Xponential Fitness, Inc. sees FY2021 revenue of $147-148.5 million, versus the consensus of $137.8 million.

Co-Diagnostics (NASDAQ:... More

Xponential Fitness, Inc. (XPOF) Misses Q3 EPS by 19c

Xponential Fitness, Inc. (NYSE: XPOF) reported Q3 EPS of ($0.31), $0.19 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $40.9 million versus the consensus estimate of $33.96 million.

GUIDANCE:

Xponential Fitness, Inc. sees FY2021 revenue of $147-148.5 million, versus the... More